Rebuttal comments

Affiliations

Comment

Daniel B Kopans. Breast Cancer Res Treat. 2017 Nov.

. 2017 Nov;166(2):655-656.

doi: 10.1007/s10549-017-4471-6. Epub 2017 Sep 16.

No abstract available

Comment on

Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial.
Miller AB, Wall C, Baines CJ, Sun P, To T, Narod SA. Miller AB, et al. BMJ. 2014 Feb 11;348:g366. doi: 10.1136/bmj.g366. BMJ. 2014. PMID: 24519768 Free PMC article. Clinical Trial.
The Canadian National Breast Screening Studies are compromised and their results are unreliable. They should not factor into decisions about breast cancer screening.
Kopans DB. Kopans DB. Breast Cancer Res Treat. 2017 Aug;165(1):9-15. doi: 10.1007/s10549-017-4302-9. Epub 2017 May 20. Breast Cancer Res Treat. 2017. PMID: 28528449 Review.
Reply to Kopans.
Narod SA. Narod SA. Breast Cancer Res Treat. 2017 Nov;166(2):653-654. doi: 10.1007/s10549-017-4465-4. Epub 2017 Aug 30. Breast Cancer Res Treat. 2017. PMID: 28856529 No abstract available.